Hatteras Venture Advisors IV SBIC, LLC

Hatteras Venture Advisors IV SBIC, LLC discloses dealings in Clearside Biomedical, Inc. to SEC (Form 4). In total, 7 filings cover trades dated from 7 June 2016 to 19 January 2017.

On the open market, the record shows 1 purchase worth €2.6M and 4 sales worth €241k. Netting one side against the other leaves €2.3M of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant. In 2017 alone, the filings show no purchases and 3 sales.

The latest filing, published on 19 January 2017, reports an open-market sale of €82k in Clearside Biomedical, Inc. The latest purchase dates back some time: it was published 3,807 days ago, on 7 June 2016. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.